ANN ARBOR, Mich. (AP) _ Esperion Therapeutics Inc. (ESPR) on Wednesday reported a loss of $29 million in its fourth quarter.
On a per-share basis, the Ann Arbor, Michigan-based company said it had a loss of $1.29.
For the year, the company reported that its loss widened to $75 million, or $3.33 per share.
Esperion Therapeutics shares have increased 95 percent since the beginning of the year. The stock has risen 53 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ESPR at https://www.zacks.com/ap/ESPR
Keywords: Esperion Therapeutics, Earnings Report